anti-CTLA-4 fully humanized antibodies (Tikcro Technologies)

N/A

Report date: 2025/03/14 16:55:29

Base Information

Drug Nameanti-CTLA-4 fully humanized antibodies (Tikcro Technologies)
Drug Alias NameCTLA-4 checkpoint inhibitor (Tikcro Technologies)TikAb (Tikcro Technologies)immune checkpoint modulator antibodies (Tikcro Technologies)anti-CTLA-4 antibodies (Tikcro Technologies)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTikcro Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTikcro Technologies Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A